// App-Quantinova.ai

: Steadily Dropping Malignancy Rates after Pediatric Kidney Transplantation Have Now Reversed in the Most Recent Era: A Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

Researchers

Presenter

  • V. Dharnidharka

Principal Investigators

  • C. Cramer

  • A. Chua

  • A. Moudgil

  • K. Martz

  • T. Blydt-Hansen

  • J. Smith

  • A. Neu

Medical Centers

  • Washington University in St Louis, St. Louis, MO

  • Mayo Clinic, Rochester, MN

  • Duke University, Durham, NC

  • Children's Natl Medcl Ctr, Washington, DC

  • The Emmes Corporation, Rockville, MD

  • BC Children's Hospital, Vancouver, BC, Canada

  • Seattle Childrens Hospital, Seattle, WA

  • Johns Hopkins University, Baltimore, MD

Locations

  • United States

  • Canada

Companies

  • Emmes Corporation

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Transplant rejection

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved